Delivery Order SPE2DB20D2014-SPE2DB24FC53J

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $31,030.65 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a wide range of medical commodities to support military treatment programs...
This is a $12,147.85 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through August 1, 2024. This delivery order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a broad range of medical commodities to support...
This is a $74,467.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support...
This is a delivery order worth $13,703.68 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide NURTEC ODT 75 MG TABLET 8S. The delivery order has a firm fixed price and an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a $52,197.41 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG TABLET 8S. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order has a firm fixed price and does not have a...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,613.46 contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient...
This is a $23,166.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of NURTEC ODT 75 MG TABLET 8S, a medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $17,070.29 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,012.85 firm fixed price contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period through August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, under which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $14,966.40 contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC53J
    Delivery Order

This is a $17,074.06 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is a delivery order for the specified pharmaceutical product with a completion date of July 22, 2024.

Generated 10/18/24, 9:26 AM